Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 21-Jun-2019
No. of pages: 101
Inquire Before Buying

In 2018, the global Parkinson's Disease Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Parkinson's Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson's Disease Therapeutics development in United States, Europe and China.

The key players covered in this study

- GSK

- Novartis

- Boehringer Ingelheim

- Teva Pharmaceutical

- Abbvie

- Merck

- Akorn

- Kyowa Hakko Kirin Pharma

- Astellas Pharma

- Desitin Arzneimittel

- Endo Pharmaceuticals

- F.Hoffmann-La Roche

- H.Lundbeck

- Valeant

- Apokyn

- Orion

- Stada Arzneimittel

- US WorldMeds

- Valeant Pharmaceuticals

Market segment by Type, the product can be split into

- Medications Therapeutics

- Medical Devices Therapeutics

Market segment by Application, split into

- Under 40 Years Old

- 40-65 Years Old

- Above 65 Years Old

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Parkinson's Disease Therapeutics status, future forecast, growth opportunity, key market and key players.

- To present the Parkinson's Disease Therapeutics development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson's Disease Therapeutics are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Medications Therapeutics
1.4.3 Medical Devices Therapeutics
1.5 Market by Application
1.5.1 Global Parkinson's Disease Therapeutics Market Share by Application (2014-2025)
1.5.2 Under 40 Years Old
1.5.3 40-65 Years Old
1.5.4 Above 65 Years Old
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Parkinson's Disease Therapeutics Market Size
2.2 Parkinson's Disease Therapeutics Growth Trends by Regions
2.2.1 Parkinson's Disease Therapeutics Market Size by Regions (2014-2025)
2.2.2 Parkinson's Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Parkinson's Disease Therapeutics Market Size by Manufacturers
3.1.1 Global Parkinson's Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Parkinson's Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Parkinson's Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Parkinson's Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Parkinson's Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Parkinson's Disease Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Parkinson's Disease Therapeutics Market Size (2014-2019)
5.2 Parkinson's Disease Therapeutics Key Players in United States
5.3 United States Parkinson's Disease Therapeutics Market Size by Type
5.4 United States Parkinson's Disease Therapeutics Market Size by Application
6 Europe
6.1 Europe Parkinson's Disease Therapeutics Market Size (2014-2019)
6.2 Parkinson's Disease Therapeutics Key Players in Europe
6.3 Europe Parkinson's Disease Therapeutics Market Size by Type
6.4 Europe Parkinson's Disease Therapeutics Market Size by Application
7 China
7.1 China Parkinson's Disease Therapeutics Market Size (2014-2019)
7.2 Parkinson's Disease Therapeutics Key Players in China
7.3 China Parkinson's Disease Therapeutics Market Size by Type
7.4 China Parkinson's Disease Therapeutics Market Size by Application
8 Japan
8.1 Japan Parkinson's Disease Therapeutics Market Size (2014-2019)
8.2 Parkinson's Disease Therapeutics Key Players in Japan
8.3 Japan Parkinson's Disease Therapeutics Market Size by Type
8.4 Japan Parkinson's Disease Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2014-2019)
9.2 Parkinson's Disease Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type
9.4 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application
10 India
10.1 India Parkinson's Disease Therapeutics Market Size (2014-2019)
10.2 Parkinson's Disease Therapeutics Key Players in India
10.3 India Parkinson's Disease Therapeutics Market Size by Type
10.4 India Parkinson's Disease Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Parkinson's Disease Therapeutics Market Size (2014-2019)
11.2 Parkinson's Disease Therapeutics Key Players in Central & South America
11.3 Central & South America Parkinson's Disease Therapeutics Market Size by Type
11.4 Central & South America Parkinson's Disease Therapeutics Market Size by Application
12 International Players Profiles
12.1 GSK
12.1.1 GSK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Parkinson's Disease Therapeutics Introduction
12.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.1.5 GSK Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Parkinson's Disease Therapeutics Introduction
12.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Details
12.3.2 Company Description and Business Overview
12.3.3 Parkinson's Disease Therapeutics Introduction
12.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.3.5 Boehringer Ingelheim Recent Development
12.4 Teva Pharmaceutical
12.4.1 Teva Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Parkinson's Disease Therapeutics Introduction
12.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.4.5 Teva Pharmaceutical Recent Development
12.5 Abbvie
12.5.1 Abbvie Company Details
12.5.2 Company Description and Business Overview
12.5.3 Parkinson's Disease Therapeutics Introduction
12.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.5.5 Abbvie Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Parkinson's Disease Therapeutics Introduction
12.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.6.5 Merck Recent Development
12.7 Akorn
12.7.1 Akorn Company Details
12.7.2 Company Description and Business Overview
12.7.3 Parkinson's Disease Therapeutics Introduction
12.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.7.5 Akorn Recent Development
12.8 Kyowa Hakko Kirin Pharma
12.8.1 Kyowa Hakko Kirin Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Parkinson's Disease Therapeutics Introduction
12.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.8.5 Kyowa Hakko Kirin Pharma Recent Development
12.9 Astellas Pharma
12.9.1 Astellas Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Parkinson's Disease Therapeutics Introduction
12.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.9.5 Astellas Pharma Recent Development
12.10 Desitin Arzneimittel
12.10.1 Desitin Arzneimittel Company Details
12.10.2 Company Description and Business Overview
12.10.3 Parkinson's Disease Therapeutics Introduction
12.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2014-2019)
12.10.5 Desitin Arzneimittel Recent Development
12.11 Endo Pharmaceuticals
12.12 F.Hoffmann-La Roche
12.13 H.Lundbeck
12.14 Valeant
12.15 Apokyn
12.16 Orion
12.17 Stada Arzneimittel
12.18 US WorldMeds
12.19 Valeant Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Parkinson's Disease Therapeutics Key Market Segments
Table Key Players Parkinson's Disease Therapeutics Covered
Table Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Parkinson's Disease Therapeutics Market Size Market Share by Type 2014-2025
Figure Medications Therapeutics Figures
Table Key Players of Medications Therapeutics
Figure Medical Devices Therapeutics Figures
Table Key Players of Medical Devices Therapeutics
Table Global Parkinson's Disease Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Under 40 Years Old Case Studies
Figure 40-65 Years Old Case Studies
Figure Above 65 Years Old Case Studies
Figure Parkinson's Disease Therapeutics Report Years Considered
Table Global Parkinson's Disease Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Parkinson's Disease Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Parkinson's Disease Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Parkinson's Disease Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Parkinson's Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Parkinson's Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Parkinson's Disease Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Share by Manufacturers in 2018
Table Global Parkinson's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Parkinson's Disease Therapeutics Product/Solution/Service
Table Date of Enter into Parkinson's Disease Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Parkinson's Disease Therapeutics Market Size Share by Type (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Parkinson's Disease Therapeutics Market Size Share by Application (2014-2019)
Figure Global Parkinson's Disease Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Parkinson's Disease Therapeutics Revenue Market Share by Application in 2018
Figure United States Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table United States Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table United States Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure Europe Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table Europe Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table Europe Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure China Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table China Parkinson's Disease Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table China Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure Japan Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table Japan Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table Japan Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure India Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table India Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table India Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Parkinson's Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Parkinson's Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Parkinson's Disease Therapeutics Market Share (2018-2019)
Table Central & South America Parkinson's Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease Therapeutics Market Share by Type (2014-2019)
Table Central & South America Parkinson's Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease Therapeutics Market Share by Application (2014-2019)
Table GSK Company Details
Table GSK Revenue in Parkinson's Disease Therapeutics Business (2014-2019) (Million US$)
Figure GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Abbvie Recent Development
Table Merck Company Details
Table Merck Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Akorn Company Details
Table Akorn Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Akorn Recent Development
Table Kyowa Hakko Kirin Pharma Company Details
Table Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Kyowa Hakko Kirin Pharma Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Astellas Pharma Recent Development
Table Desitin Arzneimittel Company Details
Table Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2014-2019)(Million US$)
Figure Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2014-2019)
Table Desitin Arzneimittel Recent Development
Table Endo Pharmaceuticals Company Details
Table F.Hoffmann-La Roche Company Details
Table H.Lundbeck Company Details
Table Valeant Company Details
Table Apokyn Company Details
Table Orion Company Details
Table Stada Arzneimittel Company Details
Table US WorldMeds Company Details
Table Valeant Pharmaceuticals Company Details
Table Global Parkinson's Disease Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Parkinson's Disease Therapeutics Market Size Share by Regions in 2025
Figure United States Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Parkinson's Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Parkinson's Disease Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Parkinson's Disease Therapeutics Market Size by Product (2019-2025)
Figure Global Parkinson's Disease Therapeutics Market Size by Product in 2025
Table Global Parkinson's Disease Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Parkinson's Disease Therapeutics Market Size by Application (2019-2025)
Figure Global Parkinson's Disease Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Parkinson's Disease Therapeutics Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99
    Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
  • Global Amantadine Hydrochloride Market Insights, Forecast to 2029
    Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
  • Global Rasagiline Tablet Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107
    Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
  • Global Parkinsons Disease Drug Market Insights, Forecast to 2029
    Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113
    Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......
  • Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Amantadine Hydrochloride Market Research Report 2023
    Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......
  • Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs